Contineum Therapeutics, Inc. Class A Common StockCTNMNASDAQ
Loading
Year-over-year earnings per share growth rate
Latest
-8.89%
↓ 115% vs avg
Percentile
P33
Within normal range
Streak
1 qtr
Consecutive declineDecelerating
Average
60.29%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | -8.89% |
| Q3 2025 | 27.42% |
| Q2 2025 | 0.00% |
| Q1 2025 | 4.62% |
| Q4 2024 | -62.50% |
| Q3 2024 | -14.29% |
| Q2 2024 | -6.06% |
| Q1 2024 | -6.45% |
| Q4 2023 | -24.00% |
| Q3 2023 | -115.43% |
| Q2 2023 | 952.63% |
| Q1 2023 | 36.67% |
| Q4 2022 | 0.00% |